Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422433 · ClinicalTrials.gov registry record · NA
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT02422433 is a NA study of Barrett's Esophagus that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 130 participants, below the 518-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02422433, a NA study of Barrett's Esophagus, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to test the feasibility, sensitivity, and specificity of the marking Optical Frequency Domain Imaging (OFDI) capsule for diagnosing Barrett's Esophagus (BE).
Conditions Studied
Interventions
- DEVICE OFDI Capsule Marking
Study Locations (1)
Massachusetts
- Massachusetts General hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-06 |
| Est. Completion | 2029-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422433
The ClinicalTrials.gov registry entry for NCT02422433 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 518-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (75% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which OFDI Capsule Marking is the first listed.
NCT02422433 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02422433 about?
NCT02422433 is a clinical study titled "Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule". The purpose of this research is to test the feasibility, sensitivity, and specificity of the marking Optical Frequency Domain Imaging (OFDI) capsule for diagnosing Barrett's Esophagus (BE).
What is the current status of trial NCT02422433?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2014-06. Estimated completion is 2029-12.
What conditions does trial NCT02422433 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT02422433?
The interventions under investigation include: OFDI Capsule Marking (DEVICE).
Who is sponsoring clinical trial NCT02422433?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422433 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.